Shanmuganathan N, Yeung DT, Wadham C, et al. Impact of <i>ASXL1</i> at diagnosis in patients with CML receiving frontline potent TKIs: high risk of kinase domain mutations. <i>Blood</i> . 2025;146(23):2821-2832.
Article Details
Journal
Blood
Volume / Issue
Vol. 147, Issue 21
Published
May 21, 2026
Pages
2555-2555
ISSN
0006-4971
Publisher
Elsevier BV
Related Articles from this Journal
NOTCHing the MSC-endothelial interplay in the HSC niche
Simón Méndez-Ferrer
Aug 2026
10.1182/blood.2026034119
Procr+ endothelial progenitor cells govern hematopoiesis through fine-tuning mesenchymal stem cell niche signals
Chang Xu, Xue Lv et al.
Aug 2026
10.1182/blood.2025031474
Li C, Wu B, Li Y, et al. Loss of sphingosine kinase 2 promotes the expansion of hematopoietic stem cells by improving their metabolic fitness. <i>Blood</i> . 2022;140(15):1686-1701.
Aug 2026
10.1182/blood.2026035281
Haploidentical transplant, gene therapy, and standard care in sickle cell disease: a cost-effectiveness analysis
Karthik Chetlapalli, Satoko Ito et al.
Aug 2026
10.1182/blood.2025032290
Granulopoiesis under attack by mutant IDH1
Hideyo Hirai
Aug 2026
10.1182/blood.2026034486